09:12

Third Quarter 2020 Earnings & Business Update Interview

26:15

Share Magazine Presentation October 2020 - Volition

01:16:27

Volition's 2020 Capital Markets Day Video

07:27

Capital Markets Day Highlights Video - October 2020

02:57

Volition Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test.

01:55

Volition Veterinary Diagnostics Development LLC - Virtual Exhibition Welcome

03:10

The Future Of Cancer Diagnosis - Key Opinion Roundtable

13:10

Quarter Two 2020 Results and Business Update

06:47

Nu.Q COVID-19 Update - July 2020

05:20

Business Update with Cameron Reynolds

08:32

Q1 2020 Financial Results & Business Update - with GERMAN subtitles

07:49

An Interview with Cameron Reynolds regarding ASCO 2020 Abstracts.

02:43

ASCO Abstract e15542- "Performance of a Nu.Q™-H3.1 assay for lung cancer detection"

04:27

ASCO 2020 Abstract "Enrichment of circulating tumor DNA from cell free DNA of Hematopoietic origin"

09:06

ASCO Abstract e20078 “Circulating nucleosomes in hematological malignancy” - with Dr Jason Terrell

00:41

How does Nu.Q(TM) Capture work?

09:27

Proactive Investors interview Cameron Reynolds regarding First Quarter 2020 Financial Results

08:02

First Quarter 2020 Financial Results and Business Update

02:26

Volition’s Nu.Q(TM) Vet Assay Detects Two Common Canine Cancers

01:47

Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies

08:06

Volition Corporate Film, March 2020

07:11

2019 Full Year Earnings with German Subtitles

07:11

2019 Results Video with French Subtitles

06:38

Proactive Investors interview Cameron Reynolds regarding 2019 Earnings Results & Business Update

07:12

VolitionRx Limited 2019 Full Year Earnings Results

01:40

Cameron Reynolds speaking about Volition's Assay Development Program

04:32

An interview with Cameron Reynolds - highlights of 2019 and the closing of the Octamer Acquisition

03:36

Volition announces Strategic Acquisition

02:57

VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million Eurostars Cash Grant.

03:42

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

00:33

Healthcare Week 2020 - invitation to meet Volition Executive Team

05:09

Proactive Investor Interview Q3 2019

07:48

Quarter Three Results & Earnings Interview

00:41

Interview with Associate Professor Heather Wilson-Robles

00:42

Interview with Brett Cornwell of Texas A&M University

00:28

Interview with Gaetan Michel, CEO of Belgian Volition

02:45

Texas A&M Signing Ceremony

09:04

VOLITION Quarter 2 2019 Earnings Call

02:12

Volition Veterinary Subsidiary Formed & its CEO appointed

04:08

Proactive Investors Q1 Interview

08:19

Quarter 1 2019 Earnings and Business Update with Cameron Reynolds

03:27

Summary with Chief Executive Officer, Cameron Reynolds

16:02

Associate Professor Heather Wilson Robles and Jason Terrell present Nu.Q Vet

06:56

Professor Axel Imhof presents Nu Q Capture

18:14

CEO and CSO introductory presentation NYSE Capital Markets Day

49:55

Volition's Capital Markets Day Presentation

06:03

Capital Markets Day Highlights - April 2019

03:01

Capital Markets Day Opening Video

10:23

Full Year 2018 Results & Business Update

05:36

SAB Final

04:01

A review of the Volition lab with interviews from members of the team

04:46

The Science Behind Our Work |

03:36

Volition's Corporate Video